Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - A systematic review and meta-analysis

International Journal of Clinical Practice

Volumn 65, Issue 6, 2011, Pages 674-678

  Trikudanathan, G ^a   Israel, J ^b   Cappa, J ^b   O'Sullivan, D M ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ARTICLE; BACTERIAL PERITONITIS; CASE CONTROL STUDY; DISEASE ASSOCIATION; DRUG USE; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLISHING; SPONTANEOUS BACTERIAL PERITONITIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ADULT; AGED; ANTACIDS; BACTERIAL INFECTIONS; GASTROINTESTINAL DISEASES; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; PERITONITIS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79956089546     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02650.x     Document Type: Article

References (31)

1. Shaheen NJ, Hansen RA, Morgan DR, et al., The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101: 2128-38. (Pubitemid 44337640)
2. Coté GA, Howden CW,. Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep 2008; 10: 208-14.
3. Corley DA, Kubo A, Zhao W, Quesenberry C,. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 2010; 139: 93-101.
4. Johnstone J, Nerenberg K, Loeb M,. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Aliment Pharmacol Ther 2010; 31: 1165-77.
5. Leonard J, Marshall JK, Moayyedi P,. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007; 102: 2047-56; quiz 2057. (Pubitemid 47301504)
6. Bajaj JS, Zadvornova Y, Heuman DM, et al., Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 2009; 104: 1130-4.
7. Bulsiewicz WJ, Scherer JR, Feinglass JM, Howden CW, Flamm SL,. 63 Proton pump inhibitor (PPI) use is independently associated with spontaneous bacterial peritonitis (SBP) in cirrhotics with ascites. Gastroenterology 2009; 136 (5, Suppl. 1): A-11.
8. Goel GA, Deshpande A, Lopez R, et al., S1915 Proton pump inhibitor (PPI) use is associated with spontaneous bacterial peritonitis (SBP) in cirrhosis (Cir). Gastroenterology 2010; 138 (5, Suppl. 1): S-816.
9. Sheer TA, Runyon BA,. Spontaneous bacterial peritonitis. Dig Dis 2005; 23: 39-46. (Pubitemid 40827661)
10. Campbell MS, Obstein K, Reddy KR, Yang Y,. Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci 2008; 53: 394-8. (Pubitemid 351170039)
11. Bauer TM, Steinbrückner B, Brinkmann FE, et al., Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001; 96: 2962-7. (Pubitemid 32959540)
12. Parkman HP, Urbain JL, Knight LC, et al., Effect of gastric acid suppressants on human gastric motility. Gut 1998; 42: 243-50. (Pubitemid 28212180)
13. Stroup DF, Berlin JA, Morton SC, et al., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. (Pubitemid 30214957)
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60. (Pubitemid 37088507)
15. Angeloni S,. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol 2008; 14: 2757.
16. Nobre SR, Cabral JEP, Gomes JJF, Leitão MC,. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol 2008; 20: 1176-81.
17. Thuluvath PJ, Morss S, Thompson R,. Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterology. 2001; 96: 1232-6. (Pubitemid 32319166)
18. Titõ L, Rimola A, Ginès P, et al., Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8: 27-31. (Pubitemid 18092054)
19. Quiqley E,. Gastrointestinal dysfunction in liver disease and portal hypertension. Dig Dis Sci 1996; 41: 557-61. (Pubitemid 26116414)
20. Llovet JM, Bartolí R, March F, et al., Translocated intenstinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol 1998; 28: 307-13. (Pubitemid 28116439)
21. Chang CS, Chen GH, Lien HC, Yeh HZ,. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 1187-90.
22. Lodato F, Azzaroli F, Di Girolamo M, et al., Proton pump inhibitors in cirrhosis: tradition or evidence based practice? World J Gastroenterol 2008; 14: 2980-5.
23. Kirk AP, Dooley JS, Hunt RH,. Peptic ulceration in patients with chronic liver disease. Dig Dis Sci 1980; 25: 756-60. (Pubitemid 11226020)
24. Siringo S, Burroughs AK, Bolondi L, et al., Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995; 22: 633-41.
25. Chen LS, Lin HC, Hwang SJ, et al., Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 1996; 11: 59-64.
26. Vergara M, Calvet X, Roqué M,. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002; 14: 717-22. (Pubitemid 34753954)
27. Lo G, Yu H, Chan Y, et al., The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc 2005; 62: 350-6. (Pubitemid 41187934)
28. Shaheen NJ, Stuart E, Schmitz SM, et al., Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology 2005; 41: 588-94. (Pubitemid 40289507)
29. Kalaitzakis E, Björnsson E,. Inadequate use of proton-pump inhibitors in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2008; 20: 512-8. (Pubitemid 351667891)
30. Chavez-Tapia NC, Tellez-Avila FI, Garcia-Leiva J, Valdovinos MA,. Use and overuse of proton pump inhibitors in cirrhotic patients. Med Sci Monit 2008; 14: CR468-72.
31. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, et al., Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol 2010; 105: 106-13.